CoChat

Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure

Open access
Houck, Keith A., Patlewicz, Grace, Richard, Ann M., Williams, Antony J., Shobair, Mahmoud A., Smeltz, Marci, Clifton, M. Scott, Wetmore, Barbara, Medvedev, Alex, Makarov, Sergei · 2021 · Toxicology
Cited by 147

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Per- and polyfluoroalkyl substances (PFAS) are a broad class of hundreds of fluorinated chemicals with environmental health concerns due to their widespread presence and persistence in the environment. Several of these chemicals have been comprehensively studied for experimental toxicity, environmental fate and exposure, and human epidemiology; however, most chemicals have limited or no data available. To inform methods for prioritizing these data-poor chemicals for detailed toxicity studies, we evaluated 142 PFAS using an in vitro screening platform consisting of two multiplexed transactivation assays encompassing 81 diverse transcription factor activities and tested in concentration-response format ranging from 137 nM to 300 μM. Results showed activity for various nuclear receptors, including three known PFAS targets--specifically estrogen receptor alpha and peroxisome proliferator receptors alpha and gamma. We also report activity against the retinoid X receptor beta, the key heterodimeric partner of type II, non-steroidal nuclear receptors. Additional activities were found against the pregnane X receptor, nuclear receptor related-1 protein, and nuclear factor erythroid 2-related factor 2, a sensor of oxidative stress. Using orthogonal assay approaches, we confirmed activity of representative PFAS against several of these targets. Finally, we identified key PFAS structural features associated with nuclear receptor activity that can inform future predictive models for use in prioritizing chemicals for risk assessment and in the design of new structures devoid of biological activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tox.2021.152789

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Research works printed but not linked: 72

  1. Abbott, 2007, Perfluorooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha, Toxicol. Sci., 98, 571, 10.1093/toxsci/kfm110 · DOI · Paper page
  2. Abe, 2017, Activation of nuclear receptor CAR by an environmental pollutant perfluorooctanoic acid, Arch. Toxicol., 91, 2365, 10.1007/s00204-016-1888-3 · DOI
  3. Ammazzalorso, 2017, N-acylsulfonamides: synthetic routes and biological potential in medicinal chemistry, Chem. Biol. Drug Des., 90, 1094, 10.1111/cbdd.13043 · DOI
  4. Anstead, 1997, The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site, Steroids, 62, 268, 10.1016/S0039-128X(96)00242-5 · DOI · Paper page
  5. Appel, 2005, PPAR-gamma agonists inhibit toll-like receptor-mediated activation of dendritic cells via the MAP kinase and NF-kappaB pathways, Blood, 106, 3888, 10.1182/blood-2004-12-4709 · DOI · Paper page
  6. Balfour, 1990, Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia, Drugs, 40, 260, 10.2165/00003495-199040020-00007 · DOI · Paper page
  7. Behr, 2018, Perfluoroalkylated substances (PFAS) affect neither estrogen and androgen receptor activity nor steroidogenesis in human cells in vitro, Toxicol. Lett., 291, 51, 10.1016/j.toxlet.2018.03.029 · DOI · Paper page
  8. Benninghoff, 2011, Estrogen-like activity of perfluoroalkyl acids in vivo and interaction with human and rainbow trout estrogen receptors in vitro, Toxicol. Sci., 120, 42, 10.1093/toxsci/kfq379 · DOI · Paper page
  9. Brieger, 2011, Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes, Toxicol. In Vitro, 25, 960, 10.1016/j.tiv.2011.03.005 · DOI
  10. Cheng, 2008, Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors, Toxicol. Sci., 106, 29, 10.1093/toxsci/kfn147 · DOI · Paper page
  11. Choi, 2012, The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases, Mol. Cells, 33, 217, 10.1007/s10059-012-2297-y · DOI · Paper page
  12. Coish, 2016, Current status and future challenges in molecular design for reduced hazard, ACS Sustain. Chem. Eng., 4, 5900, 10.1021/acssuschemeng.6b02089 · DOI
  13. Conley, 2019, Adverse maternal, fetal, and postnatal effects of hexafluoropropylene oxide dimer acid (GenX) from oral gestational exposure in Sprague-Dawley Rats, Environ. Health Perspect., 127, 37008, 10.1289/EHP4372 · DOI · Paper page
  14. Darrow, 2016, Modeled perfluorooctanoic acid (PFOA) exposure and liver function in a Mid-Ohio Valley Community, Environ. Health Perspect., 124, 1227, 10.1289/ehp.1510391 · DOI · Paper page
  15. Das, 2015, Developmental toxicity of perfluorononanoic acid in mice, Reprod. Toxicol., 51, 133, 10.1016/j.reprotox.2014.12.012 · DOI
  16. De Silva, 2020, PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding, Environ. Toxicol. Chem., 10.1002/etc.4935 · DOI · Paper page
  17. Delerive, 2000, Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators, J. Biol. Chem., 275, 36703, 10.1074/jbc.M004045200 · DOI · Paper page
  18. Dussault, 2002, A structural model of the constitutive androstane receptor defines novel interactions that mediate ligand-independent activity, Mol. Cell. Biol., 22, 5270, 10.1128/MCB.22.15.5270-5280.2002 · DOI · Paper page
  19. Egea, 2000, Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid, EMBO J., 19, 2592, 10.1093/emboj/19.11.2592 · DOI · Paper page
  20. Egea, 2002, Molecular recognition of agonist ligands by RXRs, Mol. Endocrinol., 16, 987, 10.1210/mend.16.5.0823 · doi:10.1210/mend.16.5.0823 · Paper page
  21. Filer, 2017, Tcpl: the ToxCast pipeline for high-throughput screening data, Bioinformatics, 33, 618, 10.1093/bioinformatics/btw680 · DOI · Paper page
  22. Girardi, 2019, A mortality study on male subjects exposed to polyfluoroalkyl acids with high internal dose of perfluorooctanoic acid, Environ. Res., 179, 108743, 10.1016/j.envres.2019.108743 · DOI · Paper page
  23. Grimaldi, 2015, Reporter cell lines to evaluate the selectivity of chemicals for human and zebrafish estrogen and peroxysome proliferator activated gamma receptors, Front. Neurosci., 9, 212, 10.3389/fnins.2015.00212 · DOI
  24. Grulke, 2019, EPA’s DSSTox database: history of development of a curated chemistry resource supporting computational toxicology research, Comput. Toxicol., 12, 100096, 10.1016/j.comtox.2019.100096 · DOI · Paper page
  25. Hansen, 2002, Quantitative characterization of trace levels of PFOS and PFOA in the Tennessee River, Environ. Sci. Technol., 36, 1681, 10.1021/es010780r · DOI · Paper page
  26. Humans, I.W.G.o.t.E.o.C.R.t, 2017, vol. 110
  27. Innes, 2014, Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population, BMC Cancer, 14, 45, 10.1186/1471-2407-14-45 · DOI · Paper page
  28. Intrasuksri, 1998, Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids, Gen. Pharmacol., 31, 187, 10.1016/S0306-3623(98)00029-9 · DOI
  29. Itoh, 2008, Structural basis for the activation of PPARgamma by oxidized fatty acids, Nat. Struct. Mol. Biol., 15, 924, 10.1038/nsmb.1474 · DOI · Paper page
  30. Judson, 2015, Integrated model of chemical perturbations of a biological pathway using 18 in vitro high-throughput screening assays for the estrogen receptor, Toxicol. Sci., 148, 137, 10.1093/toxsci/kfv168 · DOI · Paper page
  31. Jump, 2004, Fatty acid regulation of gene transcription, Crit. Rev. Clin. Lab. Sci., 41, 41, 10.1080/10408360490278341 · DOI · Paper page
  32. Kamm, 1982, Toxicology, carcinogenicity, and teratogenicity of some orally administered retinoids, J. Am. Acad. Dermatol., 6, 652, 10.1016/S0190-9622(82)70054-4 · doi:10.1016/s0190-9622(82)70054-4
  33. Kelly, 2009, Perfluoroalkyl contaminants in an Arctic marine food web: trophic magnification and wildlife exposure, Environ. Sci. Technol., 43, 4037, 10.1021/es9003894 · DOI · Paper page
  34. Klaunig, 2003, PPARalpha agonist-induced rodent tumors: modes of action and human relevance, Crit. Rev. Toxicol., 33, 655, 10.1080/713608372 · DOI · Paper page
  35. Ladics, 2005, Subchronic toxicity of a fluoroalkylethanol mixture in rats, Drug Chem. Toxicol., 28, 135, 10.1081/DCT-52506 · doi:10.1081/dct-52506 · Paper page
  36. Liberatore, 2020, Solvent suitability for HFPO-DA (“GenX” parent acid) in toxicological studies, Environ. Sci. Technol. Lett., 7, 477, 10.1021/acs.estlett.0c00323 · DOI · Paper page
  37. Liu, 2007, Induction of oxidative stress and apoptosis by PFOS and PFOA in primary cultured hepatocytes of freshwater tilapia (Oreochromis niloticus), Aquat. Toxicol., 82, 135, 10.1016/j.aquatox.2007.02.006 · DOI · Paper page
  38. Liu, 2015, Toxic effects of perfluorononanoic acid on the development of Zebrafish (Danio rerio) embryos, J. Environ. Sci. China (China), 32, 26, 10.1016/j.jes.2014.11.008 · DOI
  39. Love, 2002, The structural basis for the specificity of retinoid-X receptor-selective agonists: new insights into the role of helix H12, J. Biol. Chem., 277, 11385, 10.1074/jbc.M110869200 · DOI · Paper page
  40. Martin, 2010, Impact of environmental chemicals on key transcription regulators and correlation to toxicity end points within EPA’s ToxCast program, Chem. Res. Toxicol., 23, 578, 10.1021/tx900325g · DOI · Paper page
  41. Mashayekhi, 2015, Mechanistic approach for the toxic effects of perfluorooctanoic acid on isolated rat liver and brain mitochondria, Hum. Exp. Toxicol., 34, 985, 10.1177/0960327114565492 · DOI · Paper page
  42. McDonnell, 1995, Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens, Mol. Endocrinol., 9, 659
  43. Medvedev, 2018, Evaluating biological activity of compounds by transcription factor activity profiling, Sci. Adv., 4, eaar4666, 10.1126/sciadv.aar4666 · DOI
  44. Mirza, 2019, Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications, Eur. J. Med. Chem., 166, 502, 10.1016/j.ejmech.2019.01.067 · DOI · Paper page
  45. Mollenhauer, 2011, Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice, J. Environ. Sci. Health A. Tox. Subst. Environ. Eng., 46, 97
  46. Moore, 2000, Use of the nuclear receptor PXR to predict drug interactions, Toxicology, 153, 1, 10.1016/S0300-483X(00)00300-0 · DOI · Paper page
  47. Morimura, 2006, Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis, Carcinogenesis, 27, 1074, 10.1093/carcin/bgi329 · DOI · Paper page
  48. Moya, 2010, Enhanced steatosis by nuclear receptor ligands: A study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile, Chem. Biol. Interact., 184, 376, 10.1016/j.cbi.2010.01.008 · DOI
  49. Munoz, 2019, Analysis of F-53B, Gen-X, ADONA, and emerging fluoroalkylether substances in environmental and biomonitoring samples: a review, Trends Environ. Anal. Chem., 23, e00066, 10.1016/j.teac.2019.e00066 · DOI · Paper page
  50. Mylchreest, 2005, Evaluation of the reproductive and developmental toxicity of a fluoroalkylethanol mixture, Drug Chem. Toxicol., 28, 159, 10.1081/DCT-52518 · DOI
  51. Nishikawa, 2004, Involvement of the retinoid X receptor in the development of imposex caused by organotins in gastropods, Environ. Sci. Technol., 38, 6271, 10.1021/es049593u · DOI · Paper page
  52. Nolte, 1998, Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma, Nature, 395, 137, 10.1038/25931 · DOI · Paper page
  53. Noorlander, 2011, Levels of perfluorinated compounds in food and dietary intake of PFOS and PFOA in the Netherlands, J. Agric. Food Chem., 59, 7496, 10.1021/jf104943p · DOI · Paper page
  54. Peraza, 2006, The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR), Toxicol. Sci., 90, 269, 10.1093/toxsci/kfj062 · DOI · Paper page
  55. Perlmann, 1995, A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1, Genes Dev., 9, 769, 10.1101/gad.9.7.769 · DOI · Paper page
  56. Richard, 2016, ToxCast chemical landscape: paving the Road to 21st century toxicology, Chem. Res. Toxicol., 29, 1225, 10.1021/acs.chemrestox.6b00135 · DOI · Paper page
  57. Rikimaru, 2012, A new class of non-thiazolidinedione, non-carboxylic-acid-based highly selective peroxisome proliferator-activated receptor (PPAR) gamma agonists: design and synthesis of benzylpyrazole acylsulfonamides, Bioorg. Med. Chem., 20, 714, 10.1016/j.bmc.2011.12.008 · DOI
  58. Romanov, 2008, Homogeneous reporter system enables quantitative functional assessment of multiple transcription factors, Nat. Methods, 5, 253, 10.1038/nmeth.1186 · DOI
  59. Rosen, 2008, Toxicogenomic dissection of the perfluorooctanoic acid transcript profile in mouse liver: evidence for the involvement of nuclear receptors PPAR alpha and CAR, Toxicol. Sci., 103, 46, 10.1093/toxsci/kfn025 · DOI · Paper page
  60. Rosenmai, 2016, Fluorinated alkyl substances and technical mixtures used in food paper-packaging exhibit endocrine-related activity in vitro, Andrology, 4, 662, 10.1111/andr.12190 · DOI · Paper page
  61. Taylor, 2005, Central administration of perfluorooctanoic acid inhibits cutaneous inflammation, Inflamm. Res., 54, 235, 10.1007/s00011-005-1350-0 · DOI
  62. Wallen-Mackenzie, 2003, Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells, Genes Dev., 17, 3036, 10.1101/gad.276003 · DOI · Paper page
  63. Willhite, 1996, Receptor-selective retinoid agonists and teratogenic activity, Drug Metab. Rev., 28, 105, 10.3109/03602539608993994 · DOI
  64. Williams, 2017, The CompTox Chemistry Dashboard: a community data resource for environmental chemistry, J. Cheminform., 9, 61, 10.1186/s13321-017-0247-6 · DOI · Paper page
  65. Willson, 2002, PXR, CAR and drug metabolism, Nat. Rev. Drug Discov., 1, 259, 10.1038/nrd753 · DOI · Paper page
  66. Wincent, 2012, Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor, Proc. Natl. Acad. Sci., 109, 4479, 10.1073/pnas.1118467109 · DOI · Paper page
  67. Wolf, 2010, Developmental effects of perfluorononanoic Acid in the mouse are dependent on peroxisome proliferator-activated receptor-alpha, PPAR Res., 2010
  68. Wolfrum, 2001, Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus, Proc. Natl. Acad. Sci. U S A, 98, 2323, 10.1073/pnas.051619898 · DOI · Paper page
  69. Wright, 2014, Minireview: challenges and opportunities in development of PPAR agonists, Mol. Endocrinol., 28, 1756, 10.1210/me.2013-1427 · DOI · Paper page
  70. Xu, 2001, Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors, Proc. Natl. Acad. Sci. U S A, 98, 13919, 10.1073/pnas.241410198 · DOI · Paper page
  71. Yan, 2015, Perfluorooctanoic acid exposure induces endoplasmic reticulum stress in the liver and its effects are ameliorated by 4-phenylbutyrate, Free Radic. Biol. Med., 87, 300, 10.1016/j.freeradbiomed.2015.06.043 · DOI
  72. Zhu, 2017, Comparison of phenotypic and global gene expression changes in Xenopus tropicalis embryos induced by agonists of RAR and RXR, Toxicol. Appl. Pharmacol., 330, 40, 10.1016/j.taap.2017.07.004 · DOI

Cited by

See all 147

Metadata

Authors
Houck, K. A., Patlewicz, G., Richard, A. M., Williams, A. J., Shobair, M. A., Smeltz, M., Clifton, M. S., Wetmore, B., Medvedev, A., & Makarov, S.
Venue
Toxicology
Publisher
Elsevier BV
Published
2021-06
Volume
457
Pages
152789
ISSN
0300-483X (ISSN-L)
OpenAlex
W3154725671
Cited by
147
References
16
FWCI
10.94
Type
journal article
Language
en
Open access
bronze
Funders
  • Oak Ridge Institute for Science and Education
  • U.S. Environmental Protection Agency (- d -12\u2212034)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure. https://app.cochat.ai/papers/10.1016/j.tox.2021.152789
The paper
Houck, K. A., Patlewicz, G., Richard, A. M., Williams, A. J., Shobair, M. A., Smeltz, M., Clifton, M. S., Wetmore, B., Medvedev, A., & Makarov, S. (2021). Bioactivity profiling of per- and polyfluoroalkyl substances (PFAS) identifies potential toxicity pathways related to molecular structure. Toxicology. https://doi.org/10.1016/j.tox.2021.152789

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.